1. Home
  2. RMBI vs ENTA Comparison

RMBI vs ENTA Comparison

Compare RMBI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMBI
  • ENTA
  • Stock Information
  • Founded
  • RMBI 1887
  • ENTA 1995
  • Country
  • RMBI United States
  • ENTA United States
  • Employees
  • RMBI N/A
  • ENTA N/A
  • Industry
  • RMBI Major Banks
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RMBI Finance
  • ENTA Health Care
  • Exchange
  • RMBI Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • RMBI 140.8M
  • ENTA 160.3M
  • IPO Year
  • RMBI 2019
  • ENTA 2013
  • Fundamental
  • Price
  • RMBI $13.55
  • ENTA $7.29
  • Analyst Decision
  • RMBI
  • ENTA Buy
  • Analyst Count
  • RMBI 0
  • ENTA 4
  • Target Price
  • RMBI N/A
  • ENTA $18.00
  • AVG Volume (30 Days)
  • RMBI 55.3K
  • ENTA 179.3K
  • Earning Date
  • RMBI 07-24-2025
  • ENTA 08-04-2025
  • Dividend Yield
  • RMBI 4.54%
  • ENTA N/A
  • EPS Growth
  • RMBI 2.54
  • ENTA N/A
  • EPS
  • RMBI 0.89
  • ENTA N/A
  • Revenue
  • RMBI $42,825,687.00
  • ENTA $64,462,999.00
  • Revenue This Year
  • RMBI N/A
  • ENTA N/A
  • Revenue Next Year
  • RMBI N/A
  • ENTA $0.48
  • P/E Ratio
  • RMBI $14.91
  • ENTA N/A
  • Revenue Growth
  • RMBI 2.64
  • ENTA N/A
  • 52 Week Low
  • RMBI $11.26
  • ENTA $4.09
  • 52 Week High
  • RMBI $15.15
  • ENTA $17.24
  • Technical
  • Relative Strength Index (RSI)
  • RMBI 50.00
  • ENTA 59.21
  • Support Level
  • RMBI $13.03
  • ENTA $6.95
  • Resistance Level
  • RMBI $13.91
  • ENTA $7.41
  • Average True Range (ATR)
  • RMBI 0.57
  • ENTA 0.49
  • MACD
  • RMBI -0.00
  • ENTA -0.05
  • Stochastic Oscillator
  • RMBI 54.26
  • ENTA 28.75

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: